Alzheimer's and Dementia Journal

Overview
Identity
View All

publication venue for

Altered Affect and Increased CLIP+ B cells in the Meningeal Lymphatics of 5xFAD mice are mitigated by antagonizing MHCIIassociated invariant chain (CLIP). 18. 2022
Assessment of emerging mobile connected technologies to promote outdoor mobility and transit in older adults and in those with Alzheimers disease and related dementias: Usability, stressors, barriers, and implications for policy. 16. 2020
amyloid and tau drive early Alzheimers disease decline while glucose hypometabolism drives late decline. 16. 2020
O20204: BETAWRAPIN PROTEINS SEQUESTERING AMYLOID PROTEINS INVOLVED IN ALZHEIMER'S DISEASE: UNDERSTANDING THEIR FUNCTION AND DESIGNING NOVEL, IMPROVED BETAWRAPINS AS POTENTIAL THERAPEUTICS. 14:p611-p612. 2018
P1295: DIFFERENTIATING ALZHEIMER'S DISEASE (AD), VASCULAR DEMENTIA (VAD), MILD COGNITIVE IMPAIRMENT (MCI) AND PARKINSON'S DISEASE (PD): A METAANALYSIS OF NEUROTRANSMITTERS, METABOLIC, VASCULAR AND INFLAMMATORY BIOMARKERS. 14:p400-p400. 2018
P2242: EVALUATION OF THE NEUROVASCULAR HYPOTHESES OF ALZHEIMER'S DISEASE (AD): METAANALYSIS OF GLIAL, NEURONAL AND VASCULAR BIOMARKERS. 14:p765-p766. 2018
P3169: OPTOGENETIC QUANTAL ANALYSIS OF BASAL FOREBRAIN SYNAPTIC TRANSMISSION WITH PHARMACOLOGICAL TESTING OF SYNAPTIC ACTIVITY WITH GLUTAMATE AND CALCIUM MODULATORS. 14:p1132-p1133. 2018
[P1127]: TARGETING PREDEMENTIA SYNAPTIC MECHANISMS DURING AGING AND COGNITIVE IMPAIRMENT. 13:p290-p290. 2017
[P1269]: USING CSF MARKERS TO VALIDATE THE VASCULAR HYPOTHESES OF ALZHEIMER's DISEASE (AD): A METAANALYSIS. 13:p352-p353. 2017
[P2230]: USING CSF MARKERS TO VALIDATE METABOLIC AND SYNAPTIC DYSFUNCTION HYPOTHESES OF ALZHEIMER's DISEASE (AD): METAANALYSIS. 13:p699-p699. 2017
[P2237]: USING AN IN SILICO ASSOCIATION OF CSF MARKERS WITH ALZHEIMER's DISEASE (AD) TO GENERATE NOVEL HYPOTHESES: METAANALYSIS OF METABOLOMIC DATA. 13:p701-p702. 2017
[P2537]: KNOWLEDGE BARRIERS TO IDENTIFYING ALZHEIMER'S DISEASE INCIDENCE IN GRENADA, WEST INDIES. 13:p848-p848. 2017
P3030: Oxidative degradation of arachidonic acid is increased in the vicinity of amyloid plaques in Alzheimer's disease. 11:p630-p631. 2015
P4201: Beneficial catalytic autoimmunity to betaamyloid peptide. 8:p706-p706. 2012
P2253: Catecholamines and Amyloid. 7:s392-s393. 2011
P3032: Novel, highly translational learning assessment in a mouse model of Alzheimer's disease. 7:s525-s525. 2011
P4148: Increased Oxidative Damage at Plaques and Astrocytes; A Lipid Modification may be Prevented by Metal Binding. 6:e67-e67. 2010
P4037: Novel agedependent learning deficits in a mouse model of Alzheimer's disease: Implications for translational research. 5:p442-p442. 2009
Translating science into public health practice: lessons from physical activity interventions.. 3:S52-S57. 2007